학술논문
FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's disease
Document Type
Artikel
Author
Source
Alzheimer's research & therapy. 10(1):108
Subject
Language
English
English
English
ISSN
1758-9193